Suraksha Diagnostic Limited paid a fine of ₹2,360 to the National Stock Exchange of India (NSE) after delaying the submission of its shareholding pattern for the quarter ended June 30, 2026, by one day.

The company received a notice from the NSE on August 31, 2026, citing non-compliance with Regulation 31 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The total penalty included a base fine of ₹2,000 plus GST of ₹360. The payment was completed on September 29, 2026, within the stipulated timeline to avoid further regulatory action such as the freezing of promoter holdings.

Board response and remedial measures

The Board of Directors convened on October 14, 2026, to formally address the non-compliance. During the meeting, the Board took note of the delay and the remedial steps already undertaken by the secretarial team. The directors advised the team to exercise utmost care in ensuring timely submission of all statutory filings to prevent recurrence.

The Board emphasized strengthening internal monitoring mechanisms and compliance controls. This directive aims to minimize the risk of future delays in regulatory disclosures. The company stated it remains committed to maintaining high standards of corporate governance.

Financial impact assessment

The company confirmed that the fine had no material impact on its financial operations or other activities. The delay was isolated to the specific quarterly filing deadline for the shareholding pattern.

What the numbers show

The incident highlights a procedural lapse rather than a financial distress signal. The fine amount of ₹2,360 is immaterial relative to the operational scale of a listed entity, yet the regulatory consequence was significant: failure to pay within 15 days would have triggered the freezing of promoter shareholdings. The prompt payment within the window demonstrates that while the initial reporting control failed, the escalation protocol functioned effectively to mitigate severe regulatory penalties.

Suraksha Diagnostic Ltd appointed Shreya Arora as Company Secretary and Compliance Officer effective October 14, 2026. The appointment was approved by the Board of Directors based on the recommendation of the Nomination and Remuneration Committee.

The decision was taken during a board meeting held on Wednesday, October 14, 2026. The meeting commenced at 4:30 pm and concluded at 4:40 pm. This intimation was filed under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Profile of the new appointee

Arora is an Associate Member of the Institute of Company Secretaries of India (ICSI). She holds a Bachelor of Commerce (B.Com. Hons.) degree from the University of Calcutta and a Bachelor of Laws (LL.B. Hons.) degree from Bankura University.

Her professional background includes over 12 years of experience in corporate secretarial functions, legal affairs, and regulatory compliance. Prior to joining Suraksha Diagnostic, she served as Company Secretary and Legal Head at Kutchina Home Makers Private Limited. Her expertise spans corporate governance, statutory compliance, and legal matters.

Board meeting details

The board meeting addressed two primary items:

1. Appointment of the Company Secretary and Compliance Officer.
2. Comments on the delay in filing the shareholding pattern with the National Stock Exchange of India Limited.

The company signed the disclosure with Ritu Mittal, Joint Managing Director and CEO.